13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-13, with 113 holding rows worth $2,212,480,490.
- Accession
- 0001011438-26-000516
- Filer
- CIK 1773195
- Filed
- 2026-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 113 entries on the cover page, a total value of $2,212,480,490 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,212,480,490 with VALUE read as dollars as filed, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | G76279101 | SHS | 3,750,000 | $132,712,500 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 987,000 | $131,004,510 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 1,279,134 | $113,561,517 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,595,000 | $96,274,200 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 5,250,000 | $96,180,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 650,000 | $69,303,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 185,000 | $61,936,150 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 1,125,000 | $58,944,375 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 590,000 | $56,150,300 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 826,109 | $55,762,358 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 2,900,000 | $53,592,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 550,000 | $46,854,500 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 250,000 | $46,820,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 330,000 | $43,975,800 | dollars as filed | |
| FIRST TRACKS BIOTHERAPEUTICS | 337185102 | ORD SHS *A* | 2,032,012 | $40,884,081 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 400,000 | $38,992,000 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 1,172,487 | $38,926,568 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 500,000 | $35,015,000 | dollars as filed | put |
| NUVALENT INC COM | 670703107 | Stock | 275,000 | $33,962,500 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,800,172 | $33,573,208 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 475,000 | $33,264,250 | dollars as filed | call |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 750,000 | $31,545,000 | dollars as filed | call |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 10,144,562 | $27,288,872 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 5,807,611 | $27,034,429 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 700,000 | $26,047,000 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 165,000 | $25,407,525 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 500,000 | $25,375,000 | dollars as filed | |
| FORTE BIOSCIENCES INC | 34962G208 | COMMON STOCK | 1,145,391 | $24,339,559 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 20,000 | $23,988,600 | dollars as filed | call |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 967,620 | $23,474,461 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 850,000 | $22,431,500 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 40,000 | $21,478,000 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 172,125 | $21,099,083 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 750,000 | $20,235,000 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,050,000 | $19,645,500 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 2,497,864 | $19,308,489 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 840,350 | $18,672,577 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 450,000 | $17,415,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 300,000 | $17,043,000 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 875,760 | $15,947,590 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 2,512,153 | $15,474,862 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 400,000 | $14,908,000 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 4,214,582 | $14,371,725 | dollars as filed | |
| Odyssey Therapeutics, Inc. | 67613T104 | COMMON STOCK | 766,346 | $14,338,334 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240QAA0 | NOTE 1.625%11/1 | 11,000,000 | $13,653,740 | dollars as filed | principal |
| OMEROS CORP | 682143102 | COM | 1,411,300 | $13,421,463 | dollars as filed | put |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 1,250,000 | $13,300,000 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 4,100,000 | $13,120,000 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 250,000 | $13,098,750 | dollars as filed | call |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 148,013 | $12,700,996 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 972,000 | $12,674,880 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 374,000 | $12,671,120 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 100,000 | $12,294,000 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 150,000 | $12,226,500 | dollars as filed | |
| OMEROS CORP | 682143AK8 | NOTE 9.500% 6/1 | 6,525,000 | $12,182,372 | dollars as filed | principal |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 1,750,000 | $11,917,500 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 425,000 | $11,054,250 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 1,650,000 | $10,906,500 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 250,000 | $10,727,500 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 5,543,936 | $10,311,721 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 275,000 | $9,319,750 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 706,904 | $9,316,995 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 200,000 | $9,212,000 | dollars as filed | call |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 912,397 | $8,987,110 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 1,464,303 | $8,639,388 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 175,000 | $8,060,500 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 30,000 | $8,001,600 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 4,007,881 | $7,013,792 | dollars as filed | |
| GENERATE BIOMEDICINES INC | 370920100 | COMMON STOCK | 400,000 | $6,748,000 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 500,100 | $6,646,329 | dollars as filed | put |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 200,012 | $6,388,383 | dollars as filed | |
| SOL-GEL TECHNOLOGIES LTD | M8694L137 | SHS NEW | 84,900 | $6,294,486 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 1,525,000 | $5,947,500 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 1,216,606 | $5,620,720 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 100,000 | $5,454,000 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 245,000 | $5,343,450 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 190,000 | $5,221,200 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,000,000 | $5,200,000 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P207 | COM NEW | 646,576 | $5,082,087 | dollars as filed | |
| HEMAB THERAPEUTICS HLDGS INC | 423494103 | COM SHS | 138,030 | $5,069,842 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 250,000 | $4,592,500 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 125,000 | $4,342,500 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W207 | COM SHS | 707,338 | $4,328,909 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 301,183 | $4,261,739 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 75,000 | $4,140,000 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 370,000 | $3,959,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 100,000 | $3,853,000 | dollars as filed | |
| AMANAT ACQUISITION CORP | G0375M101 | CL A ORD | 375,000 | $3,810,000 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 250,000 | $3,720,000 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 144,404 | $3,610,100 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 312,500 | $3,053,125 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,510,000 | $3,035,100 | dollars as filed | |
| SPYGLASS PHARMA INC | 85220G109 | COMMON STOCK | 131,586 | $2,929,104 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 75,000 | $2,806,500 | dollars as filed | |
| OAKTREE ACQUISITION CORP III | G6717R120 | UNIT 10/04/2029 | 250,000 | $2,750,000 | dollars as filed | |
| Celcuity Inc Note 0.250 percent 8/0 | 15102KAB6 | Convertible | 2,000,000 | $2,282,800 | dollars as filed | principal |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 200,000 | $2,272,000 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 1,070,651 | $1,820,107 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 98,999 | $1,778,022 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 153,847 | $1,769,241 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 30,000 | $1,620,000 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 100,000 | $1,457,000 | dollars as filed | call |
| EIKON THERAPEUTICS INC | 282564103 | COMMON STOCK | 98,001 | $1,278,913 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 240,963 | $1,098,791 | dollars as filed | |
| ENGENE THERAPEUTICS INC | 29286X101 | COM | 600,000 | $1,038,000 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 145,000 | $677,150 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 250,000 | $625,000 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 100,000 | $568,000 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 27,777 | $353,879 | dollars as filed | |
| ORCHESTRA BIOMED HOLDINGS IN | 68572M106 | COMMON STOCK | 33,400 | $144,121 | dollars as filed | |
| NEXTCURE INC | 65343E207 | COM NEW | 41,960 | $67,136 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 80,000 | $52,128 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 75,000 | $278 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001011438-26-000516 | this filing | 2026-08-13 | acceptance time not in the bulk data set |